Edwards Lifesciences' Q4 Update: Results Were Mixed, but Guidance Was Great

Edwards Lifesciences (NYSE: EW) delivered stellar third-quarter earnings results in October. Those results helped power the stock to a whopping 52% gain last year.

But Edwards' momentum stalled somewhat during January. That could change, though, after the company reported its fiscal 2019 fourth-quarter and full-year results after the market closed on Thursday. Here are the highlights from Edwards' Q4 update.

Image source: Edwards Lifesciences.

Continue reading

Source Fool.com